RKLB vs. HIMS
RKLB (Rocket Lab USA, Inc.) and HIMS (Hims & Hers Health, Inc.) are both stocks. RKLB operates in Aerospace & Defense (Industrials), while HIMS operates in Household & Personal Products (Consumer Defensive). Over the past 3 years, RKLB returned 179.23%/yr vs 44.53%/yr for HIMS. At a 0.42 correlation, their price movements are largely independent.
Performance
RKLB vs. HIMS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, RKLB achieves a 62.92% return, which is significantly higher than HIMS's -16.32% return.
RKLB
- 1D
- 3.24%
- 1M
- 7.76%
- YTD
- 62.92%
- 6M
- 120.42%
- 1Y
- 292.98%
- 3Y*
- 179.23%
- 5Y*
- —
- 10Y*
- —
HIMS
- 1D
- 3.74%
- 1M
- -3.89%
- YTD
- -16.32%
- 6M
- -30.55%
- 1Y
- -51.77%
- 3Y*
- 44.53%
- 5Y*
- 15.10%
- 10Y*
- —
RKLB vs. HIMS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
RKLB Rocket Lab USA, Inc. | 62.92% | 173.89% | 360.58% | 46.68% | -69.30% | 8.67% |
HIMS Hims & Hers Health, Inc. | -16.32% | 34.28% | 171.69% | 38.85% | -2.14% | -10.03% |
Correlation
The correlation between RKLB and HIMS is 0.37, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.37 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.40 |
Correlation (All Time) Calculated using the full available price history since Aug 24, 2021 | 0.42 |
Fundamentals
RKLB:
$68.81B
HIMS:
$6.20B
RKLB:
-$0.33
HIMS:
-$0.05
RKLB:
92.89
HIMS:
2.81
RKLB:
30.39
HIMS:
13.91
RKLB:
$679.58M
HIMS:
$2.37B
RKLB:
$248.43M
HIMS:
$1.70B
RKLB:
-$177.36M
HIMS:
$16.04M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RKLB vs. HIMS — Risk / Return Rank
RKLB
HIMS
RKLB vs. HIMS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Rocket Lab USA, Inc. (RKLB) and Hims & Hers Health, Inc. (HIMS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| RKLB | HIMS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +3.74 | ||
| Sortino ratioReturn per unit of downside risk | +3.59 | ||
| Omega ratioGain probability vs. loss probability | 1.39 | 0.95 | +0.44 |
| Calmar ratioReturn relative to maximum drawdown | 6.86 | -0.67 | +7.53 |
| Martin ratioReturn relative to average drawdown | 15.94 | -1.09 | +17.03 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| RKLB | HIMS | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 3.20 | -0.54 | +3.74 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.18 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.76 | 0.21 | +0.54 |
Drawdowns
RKLB vs. HIMS - Drawdown Comparison
The maximum RKLB drawdown since its inception was -82.96%, roughly equal to the maximum HIMS drawdown of -87.29%. Use the drawdown chart below to compare losses from any high point for RKLB and HIMS.
Loading charts...
Drawdown Indicators
| RKLB | HIMS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -82.96% | -87.29% | +4.33% |
Max Drawdown (1Y)Largest decline over 1 year | -43.01% | -78.06% | +35.05% |
Max Drawdown (3Y)Largest decline over 3 years | -55.49% | -78.88% | +23.39% |
Max Drawdown (5Y)Largest decline over 5 years | — | -78.88% | — |
Current DrawdownCurrent decline from peak | -24.35% | -60.47% | +36.12% |
Average DrawdownAverage peak-to-trough decline | -51.40% | -43.22% | -8.18% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 18.48% | 47.51% | -29.03% |
Volatility
RKLB vs. HIMS - Volatility Comparison
Rocket Lab USA, Inc. (RKLB) has a higher volatility of 41.86% compared to Hims & Hers Health, Inc. (HIMS) at 26.28%. This indicates that RKLB's price experiences larger fluctuations and is considered to be riskier than HIMS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| RKLB | HIMS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 41.86% | 26.28% | +15.58% |
Volatility (6M)Calculated over the trailing 6-month period | 72.23% | 66.46% | +5.77% |
Volatility (1Y)Calculated over the trailing 1-year period | 92.32% | 96.13% | -3.81% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 81.48% | 83.39% | -1.91% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 81.48% | 77.19% | +4.29% |
Dividends
RKLB vs. HIMS - Dividend Comparison
Neither RKLB nor HIMS has paid dividends to shareholders.
Financials
RKLB vs. HIMS - Financials Comparison
This section allows you to compare key financial metrics between Rocket Lab USA, Inc. and Hims & Hers Health, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
RKLB vs. HIMS - Profitability Comparison
RKLB - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Rocket Lab USA, Inc. reported a gross profit of 76.49M and revenue of 200.35M. Therefore, the gross margin over that period was 38.2%.
HIMS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Hims & Hers Health, Inc. reported a gross profit of 396.79M and revenue of 608.10M. Therefore, the gross margin over that period was 65.3%.
RKLB - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Rocket Lab USA, Inc. reported an operating income of -55.97M and revenue of 200.35M, resulting in an operating margin of -27.9%.
HIMS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Hims & Hers Health, Inc. reported an operating income of -78.32M and revenue of 608.10M, resulting in an operating margin of -12.9%.
RKLB - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Rocket Lab USA, Inc. reported a net income of -45.02M and revenue of 200.35M, resulting in a net margin of -22.5%.
HIMS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Hims & Hers Health, Inc. reported a net income of -92.12M and revenue of 608.10M, resulting in a net margin of -15.2%.
Frequently Asked Questions
RKLB and HIMS have a correlation of 0.37, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
RKLB has higher volatility (41.86%) compared to HIMS (26.28%). In terms of maximum drawdown, RKLB dropped -82.96% vs HIMS's -87.29%.
RKLB currently has the higher Sharpe Ratio (3.20 vs -0.54), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for RKLB and HIMS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer